FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Biondi Paul

2. Date of Event Requiring Statement (MM/DD/YYYY)
6/14/2018 

3. Issuer Name and Ticker or Trading Symbol

BRISTOL MYERS SQUIBB CO [BMY]

(Last)        (First)        (Middle)

BRISTOL-MYERS SQUIBB COMPANY, 345 PARK AVENUE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
SVP, Head of Strategy & BD /

(Street)

NEW YORK, NY 10154       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Market Share Units     (1) 3/10/2019   Common Stock, $0.10 par value   648.0     (2) D    
Market Share Units     (3) 3/10/2020   Common Stock, $0.10 par value   1716.0     (2) D    
Market Share Units     (4) 3/10/2021   Common Stock, $0.10 par value   3286.0     (2) D    
Market Share Units     (5) 3/10/2022   Common Stock, $0.10 par value   3707.0     (2) D    
Performance Shares     (6) 3/10/2019   Common Stock, $0.10 par value   5144.0     (6) D    
Performance Shares     (7) 3/10/2020   Common Stock, $0.10 par value   6572.0     (7) D    
Performance Shares     (8) 3/10/2021   Common Stock, $0.10 par value   5561.0     (8) D    
Restricted Stock Units     (9) 7/1/2018   Common Stock, $0.10 par value   1461.0     (10) D    
Restricted Stock Units     (11) 10/2/2021   Common Stock, $0.10 par value   2368.0     (10) D    

Explanation of Responses:
(1)  These market share units will vest on March 10, 2019.
(2)  Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.
(3)  One-half of these market share units will vest on each of March 10, 2019 and March 10, 2020.
(4)  One-third of these market share units will vest on each of March 10, 2019, March 10, 2020, and March 10, 2021.
(5)  Twenty-five percent of these market share units will vest on each of the first, second, third, and fourth anniversaries of the grant date, starting on March 10, 2019.
(6)  Each performance share converts into one share of common stock upon distribution in the first quarter of 2019, subject to a Total Shareholder Return modifier.
(7)  Each performance share converts into one share of common stock upon distribution in the first quarter of 2020.
(8)  Each performance share converts into one share of common stock upon distribution in the first quarter of 2021.
(9)  These restricted stock units will vest on July 1, 2018.
(10)  Each restricted stock unit converts into one share of common stock upon vesting.
(11)  The restricted stock units vest in three equal annual installments beginning on October 2, 2019.

Remarks:
EXHIBIT LIST: EX-24 Paul Biondi Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Biondi Paul
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK, NY 10154


SVP, Head of Strategy & BD

Signatures
/s/Lisa A. Atkins, attorney-in-fact for Paul Biondi 6/22/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Bristol Myers Squibb (PK) (USOTC:BMYMP)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bristol Myers Squibb (PK) Charts.
Bristol Myers Squibb (PK) (USOTC:BMYMP)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bristol Myers Squibb (PK) Charts.